Galit
Galit Avior, Cesarea IL
Patent application number | Description | Published |
---|---|---|
20100174366 | EUSTACHIAN TUBE DEVICE - The present invention provides a device stenting the ET. The stent (device) provides enhanced ventilation and drainage to the middle ear. Also provided is a method for inserting the device into the Eustachian tube and through the isthmus of a human subject. | 07-08-2010 |
20120191030 | EUSTACHIAN TUBE DEVICE - A device stenting the Eustachian tube is inserted through the nasopharynx and provides enhanced ventilation and drainage to the middle ear. Also provided is a method for inserting the device into the Eustachian tube and through the isthmus of a human subject. | 07-26-2012 |
Galit Denkberg, Nofit IL
Patent application number | Description | Published |
---|---|---|
20100062001 | Antibodies for selective apoptosis of cells - A recombinant isolated antibody and a pharmaceutical composition containing same, capable of specifically recognizing an MHC-peptide complex with an affinity in a nanomolar range and of inducing apoptosis in cancer or pathogen infected cells is provided. Also provided are method for treating and diagnosing cancer or pathogen infection in a subject using the recombinant isolated antibody of the present invention. | 03-11-2010 |
20100158927 | ANTIBODIES, METHODS AND KITS FOR DIAGNOSING AND TREATING MELANOMA - A method of diagnosing melanoma and antibodies capable of same are disclosed. The method comprises contacting a cell of the subject with an antibody comprising an antigen recognition domain capable of binding to an MHC-I molecule being complexed with a tyrosinase peptide, wherein the antibody does not bind the MHC-I in the absence of the complexed peptide, and wherein the antibody does not bind the peptide in an absence of the MHC, under conditions which allow immunocomplex formation, wherein a presence of the immunocomplex or level thereof is indicative of the melanoma. Methods for treating melanoma and antibodies capable of same are also disclosed. Pharmaceutical compositions comprising antibodies are also disclosed. | 06-24-2010 |
20110318369 | ANTIBODY HAVING A T-CELL RECEPTOR-LIKE SPECIFICITY, YET HIGHER AFFINITY, AND THE USE OF SAME IN THE DETECTION AND TREATMENT OF CANCER, VIRAL INFECTION AND AUTOIMMUNE DISEASE - An isolated molecule which comprises an antibody specifically bindable with a binding affinity below 20 nanomolar, preferably below 10 nanomolar, to a human major histocompatibility complex (MHC) class I being complexed with a HLA-restricted antigen and optionally further comprises an identifiable or therapeutic moiety conjugated to the antibody. | 12-29-2011 |
Galit Efron-Nitzan, Herzliya IL
Patent application number | Description | Published |
---|---|---|
20100192201 | Method and Apparatus for Excessive Access Rate Detection - A system and method for protection of Web based applications are described. Anomalous traffic can be identified by comparing the traffic to a profile of acceptable user traffic when interacting with the application. Excessive access rates are one type of anomalous traffic that is detected by monitoring a source and determining whether the number of requests that the source generates within a specific time frame is above a threshold. The anomalous traffic, or security events, identified at the individual computer networks are communicated to a central security manager. The central security manager correlates the security events at the individual computer networks to determine if there is an enterprise wide security threat. The central security manager can then communicate instructions to the individual computer networks so as to provide an enterprise wide solution to the threat. Various responsive actions may be taken in response to detection of an excessive access rate. | 07-29-2010 |
20100235918 | Method and Apparatus for Phishing and Leeching Vulnerability Detection - A system and method for protection of Web based applications are described. Anomalous traffic can be identified by comparing the traffic to a profile of acceptable user traffic when interacting with the application. Phishing and leeching are one type of anomalous traffic that is detected. The anomalous traffic, or security events, identified at the individual computer networks are communicated to a central security manager. Various responsive actions may be taken in response to detection of phishing or leeching. | 09-16-2010 |
Galit Elad-Sfadia, Hod Hasharon IL
Patent application number | Description | Published |
---|---|---|
20150238466 | LIM KINASE INHIBITORS - The invention relates to compounds for reducing or inhibiting a biological function mediated by LIMK1 or LIMK2, wherein the compounds are selected to bind the ATP-binding site and/or the substrate-binding site of LIMK. | 08-27-2015 |
Galit Fuhrmann Alpert, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20160051163 | CLASSIFYING EEG SIGNALS IN RESPONSE TO VISUAL STIMULUS - Systems and method for classifying EEG signals of a human subject generated responsive to a series of images containing target images and non-target images. The EEG signals are in a spatio-temporal representation. The time points are classified independently, using a linear discriminant classifier, to compute spatio-temporal discriminating weights that are used to amplify the spatio-temporal representation, to create a spatially-weighted representation. Principal Component Analysis is used on a temporal domain for dimensionality reduction, separately for each spatial channel of the signals, to create a projection, which is applied to the spatially-weighted representation onto a first plurality of principal components, to create a temporally approximated spatially weighted representation. The temporally approximated spatially weighted representation is classified over the channels, using said linear discriminant classifier, to yield a binary decisions series indicative of each image of the images series as either belonging to said target image or to said non-target image. | 02-25-2016 |
Galit Levitin, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20110275220 | LOW TEMPERATURE METAL ETCHING AND PATTERNING - The present invention is directed to a method and apparatus for etching various metals that may be used in semiconductor or integrated circuit processing through the use of non-halogen gases such as hydrogen, helium, or combinations of hydrogen and helium with other gases such as argon. In one exemplary embodiment of the present invention, in a reaction chamber, a substrate having a metal interconnect layer deposited thereon is exposed to a plasma formed of non-halogen gas. The plasma generated is maintained for a certain period of time to provide for a desired or expected etching of the metal. In some embodiments, the metal interconnect layer may be copper, gold or silver. | 11-10-2011 |
Galit Mazooz, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20110150976 | TRANSDERMAL DELIVERY OF OLIGOSACCHARIDES - The present invention relates to a system for facilitating transdermal delivery of oligosaccharides, The system includes an apparatus that generates micro-channels in the skin of a subject and a skin patch. The patch includes a pharmaceutical composition containing an active agent of an oligosaccharide. Particularly, the oligosaccharide has 5 to 20 monosaccharide units, such as a pentasaccharide, which exerts anticoagulant activity. The system is capable of delivering the oligosaccharides into the blood circulation for treating thromboembolic diseases. | 06-23-2011 |
Galit Meshulam-Simon, Los Altos, CA US
Patent application number | Description | Published |
---|---|---|
20090176210 | MICROBIAL REDUCTIVE DEHALOGENATION OF VINYL CHLORIDE - Compositions and methods are provided that relate to the bioremediation of chlorinated ethenes, particularly the bioremediation of vinyl chloride by | 07-09-2009 |
20120082983 | Microbial Reductive Dehalogenation of Vinyl Chloride - Compositions and methods are provided that relate to the bioremediation of chlorinated ethenes, particularly the bioremediation of vinyl chloride by | 04-05-2012 |
20140322776 | OVEREXPRESSION OF GENES THAT IMPROVE FERMENTATION IN YEAST USING CELLULOSIC SUBSTRATES - The invention relates to recombinant yeast host cells that overexpress proteins to improve glucose utilization, pentose sugar utilization and/or production of a fermentation product in a fermentation reaction. | 10-30-2014 |
20150337340 | PENTOSE FERMENTATION BY A RECOMBINANT MICROORGANISM - The present invention provides methods and compositions suitable for use in the isomerization of xylose to xylulose, as well as methods and compositions suitable for use in the conversion of xylose to xylitol and xylulose, including nucleic acid constructs, recombinant fungal host cells, and related materials. | 11-26-2015 |
Galit Meshulam-Simon, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20130143291 | PRODUCTION OF MONOTERPENES - The present invention relates to methods for producing monoterpenes, particularly tricyclene, by culturing microbial organisms that express a terpene synthase and optionally a prenyl transferase. | 06-06-2013 |
Galit Parvari, Omer IL
Patent application number | Description | Published |
---|---|---|
20120142912 | POLYCYCLIC COMPOUNDS, TERMED CALIXURENES, AND USES THEREOF - Disclosed is a novel family of macrocyclic compounds, coined calixurenes, which comprises linear and cyclic oligomers composed of alternating moieties of an aromatic unit and a ureatic unit, linked to one another via a bridging moiety. | 06-07-2012 |
Galit Shaltiel, Omer Is
Patent application number | Description | Published |
---|---|---|
20100048721 | USE OF 2,2,3,3, TETRAMETHYLCYCLOPROPANE CARBOXYLIC ACID DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS - The invention relates to the use of 2,2,3,3 tetramethylcyclopropane carboxylic acid derivative compounds for the preparation of a medicament for treating a psychiatric disorder preferably a bipolar disorder. The invention additionally relates to the use of the compounds for the preparation of an inhibitor of MIP synthase and to a pharmaceutical composition comprising the compounds for treating a psychiatric disorder. A method for treating a psychiatric disorder preferably a bipolar disorder and a method for inhibiting an enzyme having MIP synthase activity is provided. | 02-25-2010 |
Galit Shaltiel-Gold, Omer IL
Patent application number | Description | Published |
---|---|---|
20150056306 | AMORPHOUS CALCIUM CARBONATE FOR THE TREATMENT OF CALCIUM MALABSORPTION AND METABOLIC BONE DISORDERS - Provided are methods for treating calcium malabsorption and conditions associated with calcium malabsorption, employing the administration of a composition containing stable amorphous calcium carbonate. Further provided are methods for increasing bone mineral density in a bone metabolism associated disorders, diseases or conditions, employing the administration of said composition in combination with a bone resorption inhibitor. | 02-26-2015 |
20150374747 | AMORPHOUS CALCIUM CARBONATE FOR ACCELERATED BONE GROWTH - The present invention provides a method for accelerating bone growth in a subject having a bone condition, selected from the group consisting of a fracture by external force, pathological fracture, fatigue fracture, distraction osteogenesis, osteotomy, osseointegration and combinations thereof, the method employing the administration of a composition containing stable amorphous calcium carbonate, comprising at least one stabilizer. Further provided are the orally-administrable pharmaceutical compositions for use in accelerating bone growth in said bone conditions. | 12-31-2015 |
Galit Shustak, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20090232867 | Modified conductive surfaces having active substances attached thereto - Novel processes for coating metal surfaces and/or for attaching active substances to metal surfaces, objects having coated metal surfaces and/or active substances attached thereto and uses thereof in the preparation of implantable devices are disclosed. | 09-17-2009 |
Galit Shvo, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20150057215 | SOAP KIT FOR ASSSEMBLY - A soap kit that includes a plurality of soap pieces for assembly. Each soap piece is configured to engage with a geometrically conforming portion of at least another complementary soap piece, such that the soap pieces can be collectively arranged to form a unified integrated soap unit. The soap pieces may be engaged with one another while in a wet state to facilitate their adhesion. The soap pieces may then be transitioned from a wet state to a dry state to reinforce the adhesion and facilitate solidification of the soap unit. The integrated soap unit may depict a representation of an image or constitute a representation of an object. | 02-26-2015 |
Galit Yahalom, Modiin IL
Patent application number | Description | Published |
---|---|---|
20120202226 | METHOD AND SYSTEM FOR THE DETECTION OF CANCER - Disclosed are a method and kit of diagnosis of cancer in a body sample of a subject, comprising contacting the sample with at least two different suitable antigens to form at least two different complexes with antibodies present in the sample, determining the actual levels of each of said antigen-antibody complexes in said sample and establishing the ratio between the levels of the different complexes in said subject; and comparing the ratio to a predetermined ratio between antigen-antibody complexes levels formed between the same at least two antigens and samples from healthy subjects, whereby if said ratio determined in step higher or lower than a predetermined cutoff point pre-established for healthy subjects, said subject is diagnosed with cancer. The method and kit can be used for diagnosing various types of cancer, including breast, ovary, lung, prostate and colon cancer. | 08-09-2012 |
Galit Zuckerman-Stark, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20130310660 | SYSTEM AND METHOD FOR PAIN MONITORING USING A MULTIDIMENSIONAL ANALYSIS OF PHYSIOLOGICAL SIGNALS - The present invention is for a method and system for pain classification and monitoring optionally in a subject that is an awake, semi-awake or sedated. | 11-21-2013 |